This website is intended for UK healthcare professionals only Log in | Register

Video

June 2021

Webinar: ‘Haemorrhage with anticoagulants: risk reduction and reversibility’

Dr Sara Boyce, Dr Alexander (Ander) Cohen, Dr Laura Hunter, Dr Adrian Parry-Jones, Dr Vinay Sehgal

Content

In this webinar, broadcast on 20th July 2021, our expert panel discuss risk reduction and reversibility in haemorrhage with anticoagulation. To view the webinar you need to be a registered user of the BJC so please log in or register.

| View

August 2020

Webinar: Restarting cardiology services in Scotland in the COVID-19 era

Professor Adrian Brady, Professor Hany Eteiba, Professor Chim Lang, Ms Jill Nicholls, Mr Dennis Sandeman, Dr Caroline Scally

Content

In this webinar, broadcast on 16th September 2020, our panel of experts discuss how we can start to optimally deliver key services in Scotland as the pandemic continues. To view the webinar you need to be a registered user of the BJC so please log in or register.

| View

June 2020

Webinar: Restarting cardiology services in the COVID-19 era

Dr Emmanuel Ako, Dr Derek Connolly, Dr Sukhjinder Nijjer, Mr Keith Pearce, Professor Simon Ray, Dr Afsana Safa

Content

In this webinar, broadcast on 18th June 2020, our panel of experts discuss how we can start to optimally deliver key services as the pandemic eases. To view the webinar you need to be a registered user of the BJC so please log in or register.

| View

May 2020

Webinar: Cross-specialty service delivery – lessons from the COVID-19 pandemic

Professor Indranil Dasgupta, Professor Philip Kalra, Dr Barbara McGowan, Dr Lara Mitchell, Professor Simon Ray, Dr Kevin Fernando, Professor Paul Kalra

Content

In this webinar, broadcast on 2nd June 2020, our panel of experts discuss how the UK has adapted to new forms of service delivery during the COVID-19 pandemic and how this may help improve future patient care. To view the webinar you need to be a registered user of the BJC so please log in or register.

| View

October 2019

ESC 2019 highlights – Heart failure and diabetes: the DAPA-HF trial

Professor David Hare

Content

The DAPA-HF trial was hailed as a landmark study at the congress when the SGLT2 inhibitor, dapagliflozin, was shown to have an extraordinarily significant result versus placebo in reducing death and hospitilisation in patients with heart failure and reduced ejection fraction, both in those with and those without diabetes. The study is discussed by Professor David Hare (Professor of Medicine, University of Melbourne; Clinical Cardiologist, Austin Health, Victoria, Australia)

| View

October 2019

ESC 2019 highlights –
New diabetes guidelines

Professor Naveed Sattar

Content

New guidance on diabetes, pre-diabetes and cardiovascular disease from the European Society of Cardiology (in collaboration with the European Association for the Study of Diabetes) was announced at the Congress. So what’s new? We find out from Professor Naveed Sattar (Professor of Metabolic Medicine, Institute of Cardiovascular and Medical Sciences, University of Glasgow)

| View

For healthcare professionals only

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now